Jordi Esteve Selected Research

Thrombotic Thrombocytopenic Purpura

2/2021

Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jordi Esteve Research Topics

Disease

72	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 02/2003
56	Leukemia 01/2024 - 04/2003
16	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 09/2003
12	Neoplasms (Cancer) 01/2023 - 07/2004
10	Infections 01/2024 - 07/2002
9	Acute Promyelocytic Leukemia 05/2020 - 04/2008
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 03/2002
7	Philadelphia Chromosome 01/2022 - 01/2010
7	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2014 - 04/2003
6	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2023 - 10/2015
5	Chromosome Aberrations (Chromosome Abnormalities) 01/2024 - 01/2018
5	Residual Neoplasm 11/2019 - 03/2002
4	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 08/2011
4	Multiple Myeloma 12/2006 - 05/2004
3	Thrombocytopenia (Thrombopenia) 02/2024 - 11/2014
3	Neutropenia 02/2024 - 01/2020
3	COVID-19 01/2024 - 01/2021
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2023 - 09/2011
3	Acquired Immunodeficiency Syndrome (AIDS) 06/2021 - 07/2005
3	Left Ventricular Dysfunction 12/2013 - 08/2011
2	Hematologic Diseases (Blood Diseases) 06/2021 - 01/2017
2	Monosomy 01/2020 - 01/2018
2	monosomy Chromosome 7 01/2020 - 01/2018
2	Febrile Neutropenia 01/2020 - 09/2014
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2016 - 09/2014
2	Fever (Fevers) 09/2014 - 04/2008
2	Lymphoma (Lymphomas) 05/2013 - 07/2005
2	HIV Infections (HIV Infection) 07/2008 - 04/2003
2	Hemorrhage 04/2008 - 02/2008
2	Plasmacytoma 07/2004 - 05/2004
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2003 - 07/2002
1	Septic Shock (Toxic Shock Syndrome) 01/2024
1	Bacterial Infections (Bacterial Infection) 11/2023
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 11/2023
1	Hyponatremia 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Sepsis (Septicemia) 12/2022

Drug/Important Bio-Agent (IBA)

10	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2021 - 07/2004
8	AnthracyclinesIBA 01/2019 - 07/2004
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 01/2021
7	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 04/2008
5	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 05/2018 - 02/2003
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 03/2015
4	Rituximab (Mabthera)FDA Link 02/2021 - 07/2008
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2018 - 02/2008
3	venetoclaxIBA 02/2024 - 01/2020
3	Azacitidine (5 Azacytidine)FDA Link 02/2024 - 01/2020
3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2020
3	fms-Like Tyrosine Kinase 3IBA 10/2022 - 01/2020
3	fludarabineIBA 01/2021 - 01/2018
3	Enalapril FDA LinkGeneric 12/2013 - 08/2011
3	Carvedilol (Coreg)FDA LinkGeneric 12/2013 - 08/2011
3	Thalidomide (Thalomid)FDA Link 12/2006 - 05/2004
2	Antiviral Agents (Antivirals)IBA 01/2024 - 01/2023
2	Decitabine FDA Link 11/2023 - 12/2022
2	Arsenic Trioxide (Trisenox)FDA Link 03/2023 - 04/2011
2	midostaurinIBA 01/2023 - 01/2019
2	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 01/2010
2	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2021 - 10/2008
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 10/2018
2	Retinoic Acid Receptor alphaIBA 10/2021 - 05/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2021 - 09/2014
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 01/2017
2	Core Binding Factors (Core-Binding Factor)IBA 01/2020 - 09/2013
2	Sorafenib (BAY 43-9006)FDA Link 03/2019 - 01/2019
2	plerixafor FDA Link 05/2018 - 01/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2015 - 11/2010
2	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 09/2013
2	Proteins (Proteins, Gene)FDA Link 04/2007 - 09/2005
1	NucleophosminIBA 01/2024
1	nirmatrelvir and ritonavir drug combinationIBA 01/2024
1	Oxygen (Dioxygen)IBA 01/2024
1	remdesivirIBA 01/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 11/2023
1	MucinsIBA 11/2023
1	sabatolimabIBA 11/2023
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2023
1	Protein Isoforms (Isoforms)IBA 05/2023
1	Prolactin Receptors (Prolactin Receptor)IBA 05/2023
1	5'-Nucleotidase (5' Nucleotidase)IBA 12/2022
1	BI 836858IBA 12/2022
1	Monoclonal AntibodiesIBA 12/2022
1	siremadlinIBA 03/2022
1	ponatinibIBA 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022

Therapy/Procedure

39	Transplantation 01/2024 - 07/2002
30	Drug Therapy (Chemotherapy) 02/2024 - 04/2003
29	Stem Cell Transplantation 05/2024 - 03/2002
28	Therapeutics 11/2023 - 04/2003
25	Hematopoietic Stem Cell Transplantation 01/2021 - 07/2004
17	Cell Transplantation 12/2023 - 01/2016
4	Immunotherapy 11/2023 - 07/2008
4	Consolidation Chemotherapy 01/2022 - 02/2003
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2021
2	Plasma Exchange 02/2021 - 11/2014
2	Homologous Transplantation 01/2021 - 01/2018
2	Aftercare (After-Treatment) 01/2020 - 10/2008
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2017 - 07/2002
2	Induction Chemotherapy 09/2014 - 01/2012
1	Heterologous Transplantation (Xenotransplantation) 05/2023